Literature DB >> 19765871

Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.

Toshiaki Nakano1, Toshiharu Ninomiya, Shinji Sumiyoshi, Hiroshi Fujii, Yasufumi Doi, Hideki Hirakata, Kazuhiko Tsuruya, Mitsuo Iida, Yutaka Kiyohara, Katsuo Sueishi.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with increased risk of coronary heart disease. However, information regarding the histopathologic characteristics of coronary atherosclerosis in individuals with CKD is scarce. This study investigated the relationship between CKD and severity of coronary atherosclerosis in population-based autopsy samples. STUDY
DESIGN: Cross-sectional study. SETTING & PARTICIPANTS: 126 individuals randomly selected from 844 consecutive population-based autopsy samples. PREDICTOR: Estimated glomerular filtration rate (eGFR) calculated using the 6-variable Modification of Diet in Renal Disease (MDRD) Study equation. OUTCOMES: Severity of atherosclerosis in 3 main coronary arteries, including atherosclerotic lesion types defined using the American Heart Association classification; stenosis rates; and coronary calcified lesions. MEASUREMENTS: The relationship between CKD and severity of coronary atherosclerosis was evaluated using generalized estimating equation methods.
RESULTS: Frequencies of advanced atherosclerotic lesions increased gradually as eGFR decreased (33.6%, 41.7%, 52.3%, and 52.8% for eGFRs > or = 60, 45-59, 30-44, and <30 mL/min/1.73 m(2), respectively; P for trend = 0.006). This relationship was substantially unchanged even after adjustment for potential confounding factors (ORs, 1.40 [95% CI, 0.76-2.55], 2.02 [95% CI, 0.99-4.15], and 3.02 [95% CI, 1.22-7.49] for eGFRs of 45-59, 30-44, and <30 mL/min/1.73 m(2), respectively). Frequencies of calcified lesions of coronary arteries also increased gradually with lower eGFRs (P for trend = 0.02). Hypertension and diabetes were associated with increased risk of advanced coronary atherosclerosis and calcification of coronary arteries in individuals with decreased eGFR. LIMITATIONS: Cross-sectional study, absence of data for proteinuria, and extremely high proportion of aged people.
CONCLUSIONS: The autopsy findings presented here suggest that CKD is associated significantly with severity of coronary atherosclerosis. Patients with CKD should be considered a high-risk population for advanced coronary atherosclerosis. Copyright 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19765871     DOI: 10.1053/j.ajkd.2009.06.034

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  54 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients.

Authors:  Akihiro Sawai; Yoshinari Yasuda; Susumu Suzuki; Hideki Ishii; Motomitsu Goto; Sawako Kato; Mutsuharu Hayashi; Shoichi Maruyama; Toyoaki Murohara; Yutaka Oiso; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-09-24       Impact factor: 2.801

Review 3.  Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies.

Authors:  Alexandru Burlacu; Simonetta Genovesi; Carlo Basile; Alberto Ortiz; Sandip Mitra; Dimitrios Kirmizis; Mehmet Kanbay; Andrew Davenport; Frank van der Sande; Adrian Covic
Journal:  J Nephrol       Date:  2020-05-29       Impact factor: 3.902

4.  Impact of kidney function and urinary protein excretion on intima-media thickness in Japanese patients with type 2 diabetes.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Yoshiyasu Miyajima; Mihiro Fukamachi; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2015-02-03       Impact factor: 2.801

5.  Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.

Authors:  Meyeon Park; Eric Vittinghoff; Peter Ganz; Carmen A Peralta; Mary Whooley; Michael G Shlipak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-31       Impact factor: 8.311

6.  Influence of hemodialysis duration on mid-term clinical outcomes in hemodialysis patients with coronary artery disease after drug-eluting stent implantation.

Authors:  Norihiro Kobayashi; Toshiya Muramatsu; Reiko Tsukahara; Yoshiaki Ito; Hiroshi Ishimori; Keisuke Hirano; Masatsugu Nakano; Masahiro Yamawaki; Motoharu Araki; Hideyuki Takimura; Yasunari Sakamoto
Journal:  Heart Vessels       Date:  2014-12-19       Impact factor: 2.037

7.  Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.

Authors:  Farsad Afshinnia; Lixia Zeng; Jaeman Byun; Crystal A Gadegbeku; Maria Chiara Magnone; Carl Whatling; Barbara Valastro; Matthias Kretzler; Subramaniam Pennathur
Journal:  Am J Nephrol       Date:  2017-07-01       Impact factor: 3.754

8.  The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions.

Authors:  Olga Laur; Meredith A Brisco; Alexander J Kula; Susan J Cheng; Abeel A Mangi; Lavanya Bellumkonda; Daniel L Jacoby; Steven Coca; W H Wilson Tang; Chirag R Parikh; Jeffrey M Testani
Journal:  J Card Fail       Date:  2015-11-23       Impact factor: 5.712

Review 9.  Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations.

Authors:  Gautam R Shroff; Charles A Herzog
Journal:  J Am Soc Nephrol       Date:  2016-08-04       Impact factor: 10.121

10.  Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease.

Authors:  Paul F Stahls; Daniel J Lightell; Stephanie C Moss; Corey K Goldman; T Cooper Woods
Journal:  J Cardiovasc Transl Res       Date:  2012-12-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.